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Noncommunicable diseases (NCDs) are a major public health threat, particularly in developing countries. In sub-
Saharan Africa, the scarcity of reliable data on NCDs in the general population makes it difficult to develop efficient 
prevention strategies. The objective of this cross-sectional study was to assess the prevalence of 4 cardiometabolic 
NCDs among 402 private-sector workers in Dakar, Senegal: high blood pressure (HBP), diabetes, obesity, and chronic 
kidney disease (CKD).
Methods 
We collected demographic, clinical, and biological data for each worker during routine occupational health visits 
between September 1 and November 30, 2010. Multivariate analyses were performed to identify risk factors associated 
with NCDs.
Results 
Among the 402 study participants, 24.1% had HBP, 9.7% had diabetes, 16.7% were obese, and 22.4% had CKD. About 
half of participants (48.5%) were not aware of their diseases before the screening. Univariate analysis showed that age 
was significantly associated with blood pressure, fasting blood glucose, and renal function. After adjusting for age and 
sex, systolic blood pressure was correlated with renal function, and physical inactivity was significantly associated with 
obesity.
Conclusion 
Despite its small sample size, our study provides a perspective on the extent of cardiometabolic NCDs in Senegalese 
workers. Our study also suggests that targeted screening activities focusing on socio-professional groups may be 
helpful in the absence of national integrated prevention programs.
Introduction
Chronic noncommunicable diseases (NCDs) are the greatest world public health challenge of the 21st century (1,2). In 
2008, approximately 36 million deaths were attributable to NCDs; most occurred in resources-limited countries, and 
more than half were due to diabetes and cardiovascular diseases (3). The social and economic burden of NCDs is great 
because they are associated with high rates of premature deaths in adults younger than 60 (2,4). In response to this 
epidemic of NCDs, the World Health Organization (WHO) recommends population-based screening and prevention 
strategies. In sub-Saharan Africa, reliable data on NCDs at the population level are lacking (5), and in many countries 
integrated national programs that provide such data have not been implemented (2). In Senegal, previous studies of 
urban areas reported prevalence of 10.4% for hypertension (6), 17.9% for diabetes (7), and 31.2% for overweight and 
obesity (2). Staff providing primary health care services are often not equipped with skills necessary to provide care for 
NCDs, and the few medical specialists in Senegal are concentrated in the capital, Dakar. For private workers, annual 
occupational health visits are mandatory; however, health care providers often do not check patients for NCDs. If a 
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health care provider does routinely measure blood pressure and weight, other factors such as renal function and 
obesity are not assessed, even in high-risk people. This study’s objective was to assess the prevalence of 4 common 
cardiometabolic NCDs and their associated modifiable risk factors among private-sector workers in Dakar.
Methods
We performed a population-based, cross-sectional study in 2 major private-sector information technology companies 
in Dakar. A representative sample of workers was randomly selected and screened during routine occupational health 
visits for high blood pressure (HBP), diabetes, obesity, and chronic kidney disease (CKD). The inclusion criteria for the 
study were being an employee of 1 of the 2 companies and willingness to participate. Participation in the study was 
free, and we obtained informed consent from each participant. We used a questionnaire to collect demographic data. 
Those who did not want to undertake the questionnaire were excluded from the study. We estimated socioeconomic 
status of participants on the basis of their educational level and total self-reported annual income. In addition to 
demographic data, for each participant, we measured blood pressure (BP), weight, and height; assessed physical 
activity level and tobacco and alcohol use; and measured fasting blood glucose (FBG), serum creatinine, and urinary 
albumin excretion (UAE). Skilled doctors and nurses performed all measurements. To assess tobacco and alcohol use, 
we asked participants if they currently smoked, had ever smoked, and if they had formerly smoked, had they stopped 
for a year or more. For alcohol, we asked how many drinks the person consumed in a week. Anyone consuming more 
than 1 drink per week was classified as a drinker. We calculated body mass index (BMI) as weight in kilograms divided 
by height in meters squared (kg/m ). Participants were identified as having hypertension, according to the Seventh 
Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure 
standards, if they had a BP at or higher than 140/90 mm Hg or had taken antihypertensive drugs in the previous 2 
weeks (8). Participants with FBG at or higher than 1.26 g/L or who were on antidiabetic drug therapy were described 
as having diabetes. Participants with a BMI of 30 or higher were considered obese (9). Glomerular filtration rate (GFR) 
was estimated by using the Modification of Diet in Renal Disease (MDRD) equation, and UAE was measured with 
urine strips. CKD was defined according to National Kidney Foundation guidelines (estimated GFR <60 mL/min or 
presence of albuminuria detected in 1 morning urine sample using Combur-Test (Roche diagnostics, Mannheim, 
Germany) (10). We assessed participants’ awareness of a diagnosis of an NCD by asking if they had been told by a 
health professional during the previous 12 months that they had the disease or if they were undergoing a 
pharmacological or nonpharmacological treatment of the disease. Physical inactivity was defined as less than 30 
minutes per day of moderate-intensity aerobic activity or less than 20 minutes per day of vigorous-intensity aerobic 
physical activity or the equivalent (11). Those with abnormal laboratory values were referred to a physician for further 
examination and treatment. Statistical analyses were performed with SPSS 16.0 (IBM Corporation, Chicago, Illinois). 
Continuous variables were presented as mean (standard deviation), and categorical variables were expressed as 
percentage. We used χ  test and Student t test, as appropriate, to compare proportion and means. We used multiple 
regression analysis to assess the likelihood of different NCDs according to demographic and clinical data. P ≤ .05 was 
considered significant.
Results
From a target population of 756 workers (502 men and 254 women), we enrolled 402 (53.2%) participants in the 
study, and all of them completed the screening. All participants had received some formal education, and 86.8% had 
completed secondary or higher education. Only 15.4% of participants were of low socioeconomic level; all others had 
annual incomes over the national average. Prevalence of HBP, diabetes, obesity, and CKD in the total population was 
24.1%, 9.7%, 16.7%, and 22.4%, respectively (Table 1). Thirty-two percent of participants with hypertension, 23.0% 
with diabetes, 17.6% who were obese, and 89.0% with CKD were not aware of their diseases before the screening.
More than half of participants with a diagnosed NCD had 2 diseases or more (Table 2). This comorbidity was most 
remarkable in participants with diabetes, who all had an associated NCD.
According to univariate analyses, as age increased, so did blood pressure (odds ratio [OR], 2.33; P = .04), FBG (OR, 
1.14; P = .05), and eGFR (OR, 0.56; P < .01); physical inactivity was associated with male sex (OR, 0.67; P = .03). 
Socioeconomic status, education level, and sex were not correlated with BP, FBG, BMI, or eGFR. After multivariate 
regression analysis adjusting for age and sex, only SBP was correlated with an eGFR lower than 60 mL/min/1.73 m  
(OR, 2.1; P = .02), and physical inactivity was associated with a 40% increased risk for obesity (OR, 1.4; P = .01).
Discussion
Data on the epidemiology of NCDs in sub-Saharan Africa are scarce and mainly represented by reports from South 
Africa. Few reports came from west Africa (5,12). Our study shows high prevalence of NCDs in Senegalese private-
sector workers. Hypertension was the most frequent NCD observed in our study. Reported prevalence in sub-Saharan 
Africa is between 6% and 48% (5,13,14) with a large rural-urban disparity and large increase with age (12,15,16). Early 
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High-income countries are still the most affected by the epidemic of NCDs, but the number of people with 
hypertension is expected to increase during the next few years by 80% in developing countries and by 24% in the 
developed world (18).
Unexpectedly, CKD (low eGFR or albuminuria) was, after HBP, the most frequent NCD in our population. Population-
based studies showed lower prevalence in adults living in the Congo (12.4%) and Ghana (13.2%) (19,20). These 
findings are alarming because low eGFR is a predictor of cardiovascular events and all-cause mortality (21), and even 
low-level albuminuria (1+) increases risk for cardiovascular disease by 30% (22).
Obesity in our population did not reach proportions observed in developed countries (2), but its prevalence was 
consistent with previously reported data in sub-Saharan African adults (5,13,23,24). However, obesity progresses 
faster in developing countries, and prevalence has doubled over the last 3 decades (25). The high prevalence of obesity 
and overweight could be related to higher frequency of physical inactivity among Senegalese workers compared with 
data for workers in low-income countries (18% in men and 21% in women) (2).
Diabetes prevalence in our study group was similar to the global prevalence, which in 2008 was estimated to be 9.8% 
for men and 9.2% for women (26). In sub-Saharan Africa, reported prevalence from community-based studies ranges 
from 0% to 16.0% with marked rural-urban differences (5,27). A recent screening of adults living in Dakar showed that 
17.9% of participants had FBG at or higher than 1.10 g/L (7).
The high prevalence of NCDs among participants in our study contrasts with their low rate of disease awareness 
despite relatively high educational levels. Ignorance of disease risk is commonly found in studies addressing NCDs 
(14,28,29).
Our study has several limitations. First, we restricted our sample size to a specific profession that may not be 
representative of the whole Senegalese population. Second, the ranges for BMI we used in our study may not be 
appropriate for African populations and may need to be lowered, just as they were lowered for Asians (30). Third, 
measuring UAE in only 1 urine specimen could result in false-positive and false-negative results (31), and estimation of 
GFR in black Africans using the MDRD equation may overestimate renal function, particularly in people older than 60 
years (20).
Evidence demonstrates that globalization of lifestyle and dietary habits is contributing to an epidemiological transition 
in middle and low-income countries (2). Concomitantly with infectious diseases, NCDs are growing rapidly while 
health care resources remain scarce (4). WHO recommends early detection and prevention of NCD risk factors in high-
risk populations as cornerstone strategies for dealing with this new paradigm (2,3). However, identification of high-
risk individuals might be difficult in sub-Saharan Africa where most of the population does not consult a health care 
professional for preventive care because of the shortage and inaccessibility of health care resources (32,33). In this 
context, any visit to a health care professional should be treated as an opportunity to assess individual risk for NCDs. 
HIV prevention and management programs in many African countries have developed strong health infrastructures 
and human resources that could be used for NCD programs. Compared with the majority of unemployed people in 
Senegal, many socio-professional groups are more able to afford regular medical check-ups because they have health 
coverage. Also, for private companies employing Senegalese workers, such preventive health strategies would be cost-
effective inasmuch as one of the most significant socioeconomic effects of NCDs is the high financial cost of health 
insurance and loss of productivity (4).
Despite these limitations, our study provides a perspective on the burden of cardiovascular and metabolic diseases in a 
segment of the Senegalese population. Hypertension and CKD are the most frequent NCDs in this population, and 
awareness is low. Opportunistic screening for common preventable risk factors could improve early detection and 
management of NCDs in resource-limited countries like Senegal.
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Table 1. Demographic and Clinical Characteristics of Participants (N = 402), 
Study of Prevalence of Noncommunicable Diseases (NCDs) in Senegalese 
Workers, 2010
Characteristic All Participants (N = 402) Men (n = 266) Women (n = 136) P Value
Demographic
Age, mean (SD), y 46.2 (7.6) 46.9 (7.7) 44.7 (7.3) .01
Personal history of NCDs 81 (20.1) 49 (18.4) 32 (23.5) .14
Family history of NCDs 165 (41.0) 89 (33.4) 76 (55.9) .82
Tobacco use 28 (7) 20 (7.5) 8 (5.9) .54
Alcohol use 54 (13.5) 48 (18.0) 6 (4.4) .001
Physical inactivity 174 (43.3) 106 (39.8) 68 (50.0) .05
Clinical
Systolic BP, mm Hg 131.0 (22.0) 131.3 (21.0) 130.5 (21.0) .81
Diastolic BP, mm Hg 82.9 (12.7) 82.8 (13.0) 83.0 (12.2) .71
Hypertension stage 1 49 (12.1) 32 (12.0) 18 (13.2) .72
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Characteristic All Participants (N = 402) Men (n = 266) Women (n = 136) P Value
BMI, kg/m 25.9 (4.3) 25.3 (4.0) 27.1 (4.7) .002
<25 9 (2.2) 8 (3.0) 1 (0.7) .005
≥25 to <30 323 (81.0) 221 (55) 102 (75) .01
≥30 67 (16.7) 34 (12.8) 33 (24.2) .48
FBG, g/L 1.04 (0.3) 1.06 (0.32) 1.01 (0.96) .11
<1.10 319 (79.6) 201 (75.5) 118 (86.7) .44
1.11 to <1.25 43 (10.7) 33 (12.8) 10 (7.3) .29
≥1.26 39 (9.7) 31 (11.6) 8 (5.8) .43
Serum creatinine, mg/dL 1.1 (0.3) 0.9 (0.4) 1.0 (0.3) .60
eGFR, ml/min 99.8 (23.5) 99.6 (24.8) 97.8 (22.4) .90
Albuminuria >1g/L 22 (5.5) 15 (5.6) 07 (5.1) .42
CKD stage 1 50 (12.4) 34 (12.8) 16 (11.7) .21
CKD stage 2 32 (8.2) 20 (5.7) 12 (8.8) .18
CKD stage 3 8 (2.0) 5 (0.3) 3 (2.2) .53
Abbreviations: SD, standard deviation; BP, blood pressure; BMI, body mass index; FBG, fasting blood glucose; eGFR, 
estimated glomerular filtration rate; CKD, chronic kidney disease. 
 All values are expressed as n (%), unless otherwise indicated. 
 BP between 140/90 mm Hg and 159/99 mm Hg. 
 BP ≥160/100 mm Hg. 
 Estimated glomerular filtration rate according to Modification of Diet in Renal Disease equation. 
 CKD stage 1 is an eGFR ≥90 ml/min, or the presence of albuminuria, or both. 
 CKD stage 2 is an eGFR 60–89 mL/min, or the presence of albuminuria, or both. 
 CKD stage 3 is an eGFR 30–59 mL/min, or the presence of albuminuria, or both.
 
Table 2. Distribution of Noncommunicable Diseases (NCDs) and Association 
of Diseases in Participants With Detected NCDs, Study of Prevalence of 
Chronic Cardiovascular and Metabolic Diseases in Senegalese Workers (N = 402), 
2010
NCD Participants with NCDs, n (%) All participants, %
Participants with 1 NCD
Obesity 32 (17.8) 8.0
CKD 28 (15.5) 7.0
HBP 28 (15.5) 7.0
Diabetes 0 0.0
Participants with 2 NCDs
HBP and CKD 40 (22.2) 10.0
Diabetes and obesity 18 (10.0) 4.5
Diabetes and CKD 5 (2.8) 1.2
Diabetes and HBP 5 (2.8) 1.2
HBP and obesity 2 (1.1) 0.5
Participants with ≥3 NCDs
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NCD Participants with NCDs, n (%) All participants, %
HBP and diabetes and CKD 7 (3.9) 1.7
HBP and diabetes and obesity 4 (2.2) 1.0
Total 180 (100) 44.7
Abbreviations: CKD, chronic kidney disease; HBP, high blood pressure.
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